Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2021-02-23, Stock:JNJ, The news for the past five days is as follows:
2021-02-16: NEWS1: Relaxing mitigation measures will 'recapitulate what we’ve already been seeing with further sickness': Doctor.NEWS2: Storm, power outages impact vaccine distribution.NEWS3: South Africa restarts its vaccine drive as the first country to use the Johnson & Johnson shot.NEWS4: Is AstraZeneca Stock A Buy After U.K., Europe Authorize Covid Vaccine?.NEWS5: South Africa plans to share AstraZeneca vaccine, first J&J shots expected.NEWS6: Why the three biggest vaccine makers failed on Covid-19.
2021-02-17: NEWS1: Johnson & Johnson's COVID-19 Vaccine Inventory Is Lighter Than Expected.NEWS2: Coronavirus update: Biden administration increases vaccine doses to states; UK approves first human challenge trial.NEWS3: Johnson & Johnson has only a few million COVID-19 vaccine doses in stock as likely launch nears.NEWS4: COVID-19 cases are dropping like a rock: Morning Brief.NEWS5: Johnson & Johnson has only a few million COVID vaccine doses in stock as likely launch nears.NEWS6: 3 Surefire Stocks to Buy If the Market Crashes.NEWS7: Novavax Trips Despite Covid Vaccine License Deal; Is NVAX Stock A Buy?.NEWS8: Like Dividends? I Bet You'll Love These 3 Stocks.NEWS9: UPDATE 4-'I feel blessed', says doctor as South Africa launches vaccination drive.NEWS10: Here's Why We're Wary Of Buying Johnson & Johnson's (NYSE:JNJ) For Its Upcoming Dividend.
2021-02-18: NEWS1: Bill Gates says US can avoid a 'fall wave' of COVID-19.NEWS2: Bill Gates: with vaccine acceptance U.S. will be back to normal by fall.NEWS3: Don’t Count on an Early Surge of J&J Covid-19 Vaccines: White House.NEWS4: COVID-19 is on the run — expect the pandemic to be under control by Memorial Day.NEWS5: Vaccine Boosters for South African Strain Look More Likely to Be Needed.NEWS6: Here's Why High Dividend Stocks Remain An Attractive Choice.NEWS7: J&J Seeks FDA Authorization For Covid Vaccine; Is JNJ Stock A Buy Now?.NEWS8: 1 Effective Way Investors Can De-Risk Their Portfolios.NEWS9: Johnson & Johnson COVID-19 Vaccine Approval Could Be Near But The Company Is Low On Supply.
2021-02-19: NEWS1: Doctor Gawande on vaccine rollout: ‘6-8 weeks to work through’ priority groups.NEWS2: Novavax Surges Against On Vaccine Supply Deal; Is NVAX Stock A Buy?.NEWS3: Novavax Surges Against On Vaccine Supply Deal; Is NVAX Stock A Buy?.NEWS4: Global case tally for COVID climbs above 110.4 million as G-7 gathers to discuss vaccine equity.NEWS5: Pfizer, Seeking Big Sales Of Covid-19 Vaccine, Adds to Its Lead.NEWS6: J&J submits application for its COVID-19 vaccine to the WHO.NEWS7: UPDATE 2-J&J applies to WHO for emergency use listing of COVID-19 vaccine.NEWS8: Johnson & Johnson Announces Submission to World Health Organization for Emergency Use Listing of Investigational Single-Shot Janssen COVID-19 Vaccine Candidate.
2021-02-22: NEWS1: UPDATE 2-Pfizer to ship 13 mln COVID-19 vaccine doses per week to U.S. by mid-March, says executive.NEWS2: Coronavirus update: US surpasses 500K deaths; FDA addresses variants and vaccines.NEWS3: U.S. COVID deaths top 500,000 as experts look to FDA meeting on J&J’s one-dose vaccine.NEWS4: Why Novavax Stock Sank Today.NEWS5: U.S. edges closer to half a million COVID deaths as experts look to FDA meeting on J&J’s one-dose vaccine.NEWS6: Sanofi and GlaxoSmithKline Start Phase 2 Trial of Delayed Covid-19 Vaccine.NEWS7: FDA committee to review J&J's COVID-19 vaccine candidate on Thursday.NEWS8: Sanofi/GlaxoSmithKline Initiate COVID-19 Vaccine Development After Setback.NEWS9: Sanofi, GSK Restart Trials on Covid-19 Vaccine After Delay.

Answer: Decrease